The first human trial of a vaccine in the southern hemisphere has begun today in Melbourne, Australia.
The vaccine being tested – with the catchy name of NVX-CoV2373 – was made by US company, Novavax. It will be tested on a group of 130 healthy adults with the first results expected in July.
There are more than 100 vaccines being developed around the world, and around a dozen have begun human testing.
Reuters